)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Onward Medical (ONWD) investor relations material
Onward Medical Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary2 Sep, 2025
Executive summary
Achieved all commercial objectives for ARC-EX/RTX US launch, selling 30 units in H1 2025, meeting sales targets and expanding to 25 clinics, with strong demand and positive user feedback.
Advanced clinical pipeline with IDE approval for Empower BP pivotal study, first human ARC-IM Lumbar Lead implant, and additional ARC-BCI implants.
Maintained financial performance in line with expectations, with H1 2025 revenue of €1.2M and cash position of €40.9M at June-end.
Expanded regulatory submissions for ARC-EX/RTX home use and CE Mark for European commercialization.
Strengthened future pipeline with new grants, partnerships, and board appointments.
Financial highlights
H1 2025 revenue reached €1.2M, up from €0.2M in H1 2024, with gross profit of €1.0M and operating loss of €21.0M.
Net loss for H1 2025 was €21.2M, compared to €18.3M in H1 2024.
Cash position at June 30, 2025 was €40.9M, with €19.1M cash used during H1 2025.
Equity at June 2025 was €27.7M, down from €48.0M at year-end 2024.
Operating expenses increased year-over-year, mainly due to commercialization investments.
Outlook and guidance
Expecting FDA home use authorization and CE Mark for ARC-EX/RTX in Q4 2025, enabling European commercialization.
Anticipate sales acceleration in H2 2025, aiming for over 150 units sold and 100 clinics penetrated by year-end.
Empower BP pivotal study to begin enrollment in H2 2025, with interim analysis projected for H2 2026.
Additional ARC-IM and ARC-BCI implants and first-in-human studies for new indications expected in the next 12 months.
Current cash expected to fund operations into H1 2026; exploring options to bolster cash for future investments.
Impact of ARC-EX home use clearance?
Empower BP study: What is its scale and timeline?
ARC-IM: How do new indications diversify pipeline?
What enables ARC-EX sales acceleration in H2?
Empower BP interim analysis: What's its impact?
How is the extensive pipeline funded?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Onward Medical earnings date
Q3 202511 Nov, 2025
Next Onward Medical earnings date
Q3 202511 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Onward Medical N.V. is a medical technology company focused on developing innovative therapies to restore movement, function, and independence for people with spinal cord injuries. It has developed two main technology platforms: ARCIM, an implantable neurostimulation system, and ARCEX, a non-invasive transcutaneous system. These technologies are designed to improve or restore motor functions and independence in individuals affected by spinal cord injuries through targeted spinal cord stimulation. The company is engaged in ongoing clinical trials to validate and expand the application of its technologies. Onward Medical N.V. is headquartered in Eindhoven, Netherlands, and its shares are listed on Euronext Brussels and Euronext Amsterdam.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage